Smartphone Based Artificial Intelligence Platform Demonstrates High Rates of Adherence and Viral Outcome in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study

Litwin Alain H.; Shafner Laura; Agyemang Linda

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Smartphone Based Artificial Intelligence Platform Demonstrates High Rates of Adherence and Viral Outcome in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study

【24h】

Smartphone Based Artificial Intelligence Platform Demonstrates High Rates of Adherence and Viral Outcome in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study

机译：基于智能手机的人工智能平台展示了接受固定剂量LEDIPASVIR和SOFOSBUVIR的患者的高粘附和病毒结果：试点研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共1页
作者
Litwin Alain H.; Shafner Laura; Agyemang Linda;
展开▼
作者单位

Albert Einstein Coll Med Dept Med Bronx NY 10467 USA;

AiCure New York NY USA;

Albert Einstein Coll Med Dept Med Bronx NY 10467 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Smartphone Based Artificial Intelligence Platform Demonstrates High Rates of Adherence and Viral Outcome in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study [J] . Litwin Alain H., Shafner Laura, Agyemang Linda Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：基于智能手机的人工智能平台展示了接受固定剂量LEDIPASVIR和SOFOSBUVIR的患者的高粘附和病毒结果：试点研究
2. Resistance Analyses of Japanese Hepatitis C-Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies [J] . Mizokami M., Dvory-Sobol H., Izumi N., Journal of viral hepatitis. . 2016,第10期

机译：在第三阶段研究中接受Sofosbuvir或Ledipasvir / Sofosbuvir含方案的日本C型肝炎感染患者的耐药性分析
3. A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na < ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus [J] . Lim Young-Suk, Ahn Sang Hoon, Lee Kwan Sik, Hepatology international . 2016,第6期

机译：ledipasvir / sofosbuvir固定剂量联合片剂的IIIb期研究在初治和经验丰富的韩国慢性感染基因1型丙型肝炎患者中的应用
4. COVID-19 Preliminary Patient Filtering based on Regular Blood Tests using Auto-Adaptive Artificial Intelligence Platform [C] . Zoltan Czako, Gheorghe Sebestyen, Anca Hangan International Conference on Intelligent Computer Communication and Processing . 2020

机译：使用自适应人工智能平台基于常规血液测试的COVID-19病人初步过滤
5. Conversational Artificial Intelligence and Patient Generated Health Data: Transitional Patient Applications to Improve Outcomes in the 30 Day Post-discharge Window [D] . Mazza, Kathleen . 2020

机译：会话人工智能和患者产生的健康数据：过渡患者应用，以改善30天后排出后窗口的结果
6. Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study [O] . Alain H Litwin, Laura Shafner, Brianna Norton, 2020

机译：人工智能平台展示了接受固定剂量LEDIPASVIR和SOFOSBUVIR患者的高粘附性：试点研究
7. Sofosbuvir and Ledipasvir/Sofosbuvir for the treatment of patients with Chronic Genotype 6 Hepatitis C Virus Infection: integrated analysis of Phase 2 and Phase 3 studies [O] . Chuang, WL, Gane, EJ, Hyland, RH, 2015

机译：sofosbuvir和Ledipasvir / sofosbuvir用于治疗慢性基因型6型丙型肝炎病毒感染患者：2期和3期研究的综合分析

Smartphone Based Artificial Intelligence Platform Demonstrates High Rates of Adherence and Viral Outcome in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study

著录项

相似文献

相关主题

期刊订阅